Yesterday I attended Comfort AGM during which the Chairman openly said that due to the Covid 19 pandemic, the demand for gloves far exceeds supply. As a result, the company can easily increase their selling price for their products. They are now increasing their selling price by 5-10% every month. They sell cheaper to long term customers and at higher prices to non-regular customers.
Based on the new information, I need to revise my target price for Supermax. Since Supermax has its own sale outlets in USA and many other countries, it is reasonable to assume it can increase its revenue and PAT by 15% every month.
I refer to the above report, total issued number of shares is 1,300 million.
1st quarter revenue Rm 447 million, PAT or profit after tax 71 million.
For the next 9 months, each month its PAT and revenue will be increased by 15% (compound).
1st month its revenue PAT will be 15% X 447 = 67 and revenue 447+67=514
2nd month its PAT 15% X 514 = 77 and its revenue 514+77=591
3rd month its PAT 15% X 591= 89 and its revenue 591+89=680
4th month its PAT 15%X 680= 102 and its revenue 680+102= 782
5th month its PAT 15%X782= 117 and its revenue 782+117= 899
6th month its PAT 15%X889= 133 and its revenue 889+133= 1002
7th month its PAT 15% X 1002= 150 and its revenue 1002+150= 1152
8th month its PAT 15% X 1152= 173 and its revenue 1152+173= 1325
9th month its PAT 15% X 1325= 199 and its revenue 1325+199= 1524
Total for the whole year Rm 1178 million
EPS 1178 divided 1300 shares = 90 sen
Based on P/E 15 target price Rm 13.50
Based on P/E 20 target price Rm 18
Since the company has its own sale outlets in US and other countries, it can easily increase its selling price for gloves. Any price increase is pure profit because the company does not need additional cost to increase the selling prices.
Due to the Covid 19 pandemic, Supermax deserved to sell at P/E 20.
The World Health Organisation has just reported 150,000 new Covid 19 cases, the biggest number of Covid 19 cases in one single day. US has 2.68 million cases and 129,000 deaths and Brazil has 1.40 million cases and 60,000 deaths. Based on the continuous increase of cases in almost all the countries in the world, the pandemic is still spreading quietly rapidly. Even though vaccine is under human testing, FDA still need time to examine to approve the safe use of the vaccine. Many scientists predicted the pandemic will not be under control for at least another year.
It looks like the demand for gloves will continue to exceed supply for a long time. As a result, glove price will continue to increase and all the glove manufacturers are making more and more profit which should be reflected on their share prices.